JP2019537551A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019537551A5 JP2019537551A5 JP2019507936A JP2019507936A JP2019537551A5 JP 2019537551 A5 JP2019537551 A5 JP 2019537551A5 JP 2019507936 A JP2019507936 A JP 2019507936A JP 2019507936 A JP2019507936 A JP 2019507936A JP 2019537551 A5 JP2019537551 A5 JP 2019537551A5
- Authority
- JP
- Japan
- Prior art keywords
- water
- glatiramer acetate
- organic solvent
- fine particles
- double emulsion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 18
- 238000000034 method Methods 0.000 claims 15
- 108010072051 Glatiramer Acetate Proteins 0.000 claims 9
- FHEAIOHRHQGZPC-KIWGSFCNSA-N acetic acid;(2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2s)-2-aminopentanedioic acid;(2s)-2-aminopropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound CC(O)=O.C[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 FHEAIOHRHQGZPC-KIWGSFCNSA-N 0.000 claims 9
- 229960003776 glatiramer acetate Drugs 0.000 claims 9
- 239000003960 organic solvent Substances 0.000 claims 7
- 239000010419 fine particle Substances 0.000 claims 6
- 239000008346 aqueous phase Substances 0.000 claims 5
- 239000000839 emulsion Substances 0.000 claims 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 5
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 4
- 238000001035 drying Methods 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 2
- 229920002988 biodegradable polymer Polymers 0.000 claims 2
- 239000004621 biodegradable polymer Substances 0.000 claims 2
- 238000004108 freeze drying Methods 0.000 claims 2
- 238000002513 implantation Methods 0.000 claims 2
- 238000007918 intramuscular administration Methods 0.000 claims 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- 239000012074 organic phase Substances 0.000 claims 2
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims 2
- 238000007920 subcutaneous administration Methods 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- 238000013268 sustained release Methods 0.000 claims 2
- 239000012730 sustained-release form Substances 0.000 claims 2
- 239000007762 w/o emulsion Substances 0.000 claims 2
- 102000008186 Collagen Human genes 0.000 claims 1
- 108010035532 Collagen Proteins 0.000 claims 1
- 108010010803 Gelatin Proteins 0.000 claims 1
- 229920002201 Oxidized cellulose Polymers 0.000 claims 1
- 239000004698 Polyethylene Substances 0.000 claims 1
- 229920000331 Polyhydroxybutyrate Polymers 0.000 claims 1
- 150000008064 anhydrides Chemical class 0.000 claims 1
- 229920001400 block copolymer Polymers 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- 238000004945 emulsification Methods 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 239000011859 microparticle Substances 0.000 claims 1
- 150000002905 orthoesters Chemical class 0.000 claims 1
- 229940107304 oxidized cellulose Drugs 0.000 claims 1
- 239000005015 poly(hydroxybutyrate) Substances 0.000 claims 1
- 229920002627 poly(phosphazenes) Polymers 0.000 claims 1
- 229920001610 polycaprolactone Polymers 0.000 claims 1
- 239000004632 polycaprolactone Substances 0.000 claims 1
- -1 polyethylene Polymers 0.000 claims 1
- 229920000573 polyethylene Polymers 0.000 claims 1
- 229920002643 polyglutamic acid Polymers 0.000 claims 1
- 229920001451 polypropylene glycol Polymers 0.000 claims 1
- 229920000136 polysorbate Polymers 0.000 claims 1
- 229950008882 polysorbate Drugs 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022189936A JP2023022199A (ja) | 2016-08-28 | 2022-11-29 | 酢酸グラチラマーを含有する微小粒子を調製する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662380426P | 2016-08-28 | 2016-08-28 | |
| US62/380,426 | 2016-08-28 | ||
| PCT/IL2017/050954 WO2018042423A1 (en) | 2016-08-28 | 2017-08-28 | Process for preparing microparticles containing glatiramer acetate |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022189936A Division JP2023022199A (ja) | 2016-08-28 | 2022-11-29 | 酢酸グラチラマーを含有する微小粒子を調製する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019537551A JP2019537551A (ja) | 2019-12-26 |
| JP2019537551A5 true JP2019537551A5 (enExample) | 2020-10-08 |
| JP7232752B2 JP7232752B2 (ja) | 2023-03-03 |
Family
ID=61301634
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019507936A Active JP7232752B2 (ja) | 2016-08-28 | 2017-08-28 | 酢酸グラチラマーを含有する微小粒子を調製する方法 |
| JP2022189936A Pending JP2023022199A (ja) | 2016-08-28 | 2022-11-29 | 酢酸グラチラマーを含有する微小粒子を調製する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022189936A Pending JP2023022199A (ja) | 2016-08-28 | 2022-11-29 | 酢酸グラチラマーを含有する微小粒子を調製する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11471421B2 (enExample) |
| EP (1) | EP3503907B1 (enExample) |
| JP (2) | JP7232752B2 (enExample) |
| CN (2) | CN122097289A (enExample) |
| AU (1) | AU2017319781B2 (enExample) |
| BR (1) | BR112019003131A2 (enExample) |
| ES (1) | ES2979169T3 (enExample) |
| IL (1) | IL264824B (enExample) |
| MX (1) | MX2019001999A (enExample) |
| WO (1) | WO2018042423A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12097292B2 (en) | 2016-08-28 | 2024-09-24 | Mapi Pharma Ltd. | Process for preparing microparticles containing glatiramer acetate |
| AU2017319728B2 (en) * | 2016-08-31 | 2024-09-05 | Mapi Pharma Ltd | Depot systems comprising glatiramer acetate |
| IL316573A (en) | 2017-03-26 | 2024-12-01 | Mapi Pharma Ltd | Storage systems containing glatiramer acetate for the treatment of multiple sclerosis |
| CN111249524B (zh) * | 2020-01-18 | 2020-12-08 | 南京医科大学附属口腔医院 | 用于骨组织再生的高孔隙率聚己内酯多孔微球支架及其制备方法 |
| WO2023170493A1 (en) * | 2022-03-07 | 2023-09-14 | Hadidi Naghmeh | Drug delivery using a parenteral pharmaceutical composition |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL113812A (en) | 1994-05-24 | 2000-06-29 | Yeda Res & Dev | Copolymer-1 pharmaceutical compositions containing it and its use |
| US5945126A (en) * | 1997-02-13 | 1999-08-31 | Oakwood Laboratories L.L.C. | Continuous microsphere process |
| US8871241B2 (en) | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
| CN1398584A (zh) | 2002-07-15 | 2003-02-26 | 裴福兴 | 一种bFGF－PLGA缓释微球及其制备方法和用途 |
| US20060276390A1 (en) | 2003-07-31 | 2006-12-07 | Yeda Research And Development Co. Ltd. | Combined treatments comprising synthetic peptide copolymers for preventing graft rejection |
| US8377885B2 (en) | 2010-01-04 | 2013-02-19 | Mapi Pharma Ltd. | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| WO2011080733A1 (en) | 2010-01-04 | 2011-07-07 | Mapi Pharma Limited | Depot systems comprising glatiramer or a pharmacologically acceptable salt thereof |
| ES2601892T3 (es) | 2011-04-21 | 2017-02-16 | Mapi Pharma Limited | Pentapolímero aleatorio para el tratamiento de enfermedades autoinmunes |
| CN103169670B (zh) * | 2013-03-22 | 2016-07-06 | 深圳翰宇药业股份有限公司 | 一种醋酸格拉替雷微球及其制备方法 |
| AU2017319728B2 (en) | 2016-08-31 | 2024-09-05 | Mapi Pharma Ltd | Depot systems comprising glatiramer acetate |
| IL316573A (en) | 2017-03-26 | 2024-12-01 | Mapi Pharma Ltd | Storage systems containing glatiramer acetate for the treatment of multiple sclerosis |
-
2017
- 2017-08-28 WO PCT/IL2017/050954 patent/WO2018042423A1/en not_active Ceased
- 2017-08-28 AU AU2017319781A patent/AU2017319781B2/en active Active
- 2017-08-28 MX MX2019001999A patent/MX2019001999A/es unknown
- 2017-08-28 EP EP17845665.3A patent/EP3503907B1/en active Active
- 2017-08-28 US US16/328,572 patent/US11471421B2/en active Active
- 2017-08-28 ES ES17845665T patent/ES2979169T3/es active Active
- 2017-08-28 CN CN202511860124.1A patent/CN122097289A/zh active Pending
- 2017-08-28 CN CN201780053557.3A patent/CN109689082A/zh active Pending
- 2017-08-28 BR BR112019003131-6A patent/BR112019003131A2/pt active Search and Examination
- 2017-08-28 JP JP2019507936A patent/JP7232752B2/ja active Active
-
2019
- 2019-02-13 IL IL264824A patent/IL264824B/en unknown
-
2022
- 2022-11-29 JP JP2022189936A patent/JP2023022199A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yeo et al. | Control of encapsulation efficiency and initial burst in polymeric microparticle systems | |
| US11957785B2 (en) | Film dosage form with extended release mucoadhesive particles | |
| Jain et al. | Controlled drug delivery by biodegradable poly (ester) devices: different preparative approaches | |
| ES2292634T3 (es) | Procedimiento de transicion de fase inducida para la produccion de microparticulas que contienen agentes hidrofilos activos. | |
| HRP20221208T1 (hr) | Depot sustav koji sadrži glatiramer acetat | |
| ES2292655T3 (es) | Microparticulas y procedimiento para su preparacion. | |
| JP2011144207A5 (enExample) | ||
| HRP20250396T1 (hr) | Depo sustavi koji sadrže glatiramer acetat | |
| IL283699B (en) | Methods and preparations related to artificial nanocarriers with rapamycin in a super-saturated steady state | |
| JP2005525403A5 (enExample) | ||
| JP2006508127A5 (enExample) | ||
| JP2015522001A5 (enExample) | ||
| JP2002534392A (ja) | 黄体化ホルモン放出ホルモン類似体をカプセル化する持続放出性のマイクロスフェアおよびその調製方法 | |
| JP2016527308A (ja) | エンテカビル微小球及びこれを含む非経口投与用医薬組成物 | |
| Bouillot et al. | Protein encapsulation in biodegradable amphiphilic microspheres | |
| JP2006514923A5 (enExample) | ||
| CN103269689B (zh) | 含有生理活性肽的微粒及其制备方法和包括该微粒的药物组合物 | |
| JP2018536007A5 (enExample) | ||
| Kim et al. | Albumin loaded microsphere of amphiphilic poly (ethylene glycol)/poly (α-ester) multiblock copolymer | |
| JP2023022199A (ja) | 酢酸グラチラマーを含有する微小粒子を調製する方法 | |
| CN110769813A (zh) | 包含具有双核壳结构的难溶性喜树碱化合物的粒子、药剂学组合物及其制备方法 | |
| JPWO2022004859A5 (enExample) | ||
| TW200836770A (en) | Controlled release system and manufacture method thereof | |
| IL275448B1 (en) | Pharmaceutical compositions having a selected release duration | |
| JP2003519651A5 (enExample) |